Source: BioSpace

Smartway: Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX (testosterone undecanoate)

Marius Pharmaceuticals (Marius) and Smartway Pharmaceuticals (Smartway) are pleased to announce their strategic partnership, aimed at addressing the pressing global issue of hypogonadism through the launch of a comprehensive Early Access Program for KYZATREX (testosterone undecanoate).

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Josh Cocklin's photo - CEO of Smartway

CEO

Josh Cocklin

CEO Approval Rating

90/100

Read more